当前位置:首页 - 行情中心 - 药康生物(688046) - 财务分析

药康生物

(688046)

  

流通市值:23.76亿  总市值:47.77亿
流通股本:2.04亿   总股本:4.10亿

药康生物(688046)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.29亿元,每股收益0.07元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益213122.80万元,未分配利润44133.07万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产255943.15万元,负债42820.35万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入157,087,264.43622,186,991.12454,564,476.69295,864,533.76
营业总成本127,213,613.71486,134,284.8349,773,222.18230,524,550.76
营业利润28,210,897.29163,687,866.16124,068,286.2981,685,322.75
利润总额28,204,594.53161,287,732.53124,039,370.181,675,269.05
净利润29,479,404.17158,914,063.14117,714,006.9477,568,471
其他综合收益74,046176,652.84398,820.96487,281.13
综合收益总额29,553,450.17159,090,715.98118,112,827.978,055,752.13
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,648,107,709.61,657,522,891.611,627,275,575.631,599,838,790.55
非流动资产合计911,323,787.9920,066,986.97850,815,221.4800,458,844.79
资产总计2,559,431,497.52,577,589,878.582,478,090,797.032,400,297,635.34
流动负债合计340,772,915.39366,409,071.83307,639,003.34268,361,553.81
非流动负债合计87,430,573.9486,524,362.4387,559,185.0588,964,082.63
负债合计428,203,489.33452,933,434.26395,198,188.39357,325,636.44
归属于母公司股东权益合计2,131,228,008.172,124,656,444.322,082,892,608.632,042,971,998.9
股东权益合计2,131,228,008.172,124,656,444.322,082,892,608.632,042,971,998.9
负债和股东权益合计2,559,431,497.52,577,589,878.582,478,090,797.032,400,297,635.34
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计107,901,546.21627,423,948.94411,249,887.13269,365,202.22
经营活动现金流出小计160,506,283.34510,853,413.43374,098,403.92243,152,406.53
经营活动产生的现金流量净额-52,604,737.13116,570,535.5137,151,483.2126,212,795.69
投资活动现金流入小计713,753,844.521,973,187,738.231,752,309,699.741,232,166,598.74
投资活动现金流出小计643,359,140.591,991,797,521.641,595,117,598.321,125,417,964.74
投资活动产生的现金流量净额70,394,703.93-18,609,783.41157,192,101.42106,748,634
筹资活动现金流入小计19,950,00086,000,00086,000,00046,000,000
筹资活动现金流出小计35,994,111.7346,709,209.6142,048,52813,223,168.35
筹资活动产生的现金流量净额-16,044,111.7339,290,790.3943,951,47232,776,831.65
汇率变动对现金及现金等价物的影响-141,054.211,148,916.531,794,675.352,407,685.71
现金及现金等价物净增加额1,604,800.86138,400,459.02240,089,731.99168,145,947.05
期末现金及现金等价物余额561,598,014.01559,993,213.15661,682,486.12589,738,701.18
最新报告期:2024-05-11
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国元证券马云涛0.500.620.762024-05-11
华安证券谭国超0.480.590.712024-05-08
华西证券崔文亮,徐顺利0.470.580.732024-05-07
东吴证券张坤,朱国广0.440.540.642024-05-04
国联证券郑薇0.500.600.802024-05-04
TOP↑